Aristolactam I has been primarily studied for its potential biological activities, particularly in the context of anti-cancer research. It exhibits cytotoxic effects against certain tumor cell lines by interfering with cellular proliferation and inducing apoptosis. Some studies suggest it may act through inhibition of specific signaling pathways involved in cancer progression. Additionally, it has been investigated for anti-inflammatory and immunomodulatory properties, though research remains limited due to toxicity concerns associated with aristolactam derivatives. Its use is currently restricted to laboratory and experimental settings, mainly in pharmacological research to understand structure-activity relationships in natural products.